Self-Assembled Nanocomplexes of Oligomerized Catechins and Deoxyribonuclease-I for Synergistically Enhancing Diabetic Wound Healing

Abstract

Diabetic ulcers (DUs), a severe complication of diabetes, are characterized by impaired wound healing and contribute significantly to morbidity and mortality. A key pathological driver is the persistent accumulation of neutrophil extracellular traps (NETs), which extend inflammation and tissue damage; however, appropriate therapeutic strategies to resolve NETs remain underdeveloped. We engineered a self-assembled nanocomplex, O/DNase-I, through structural and functional integration of oligomerized epigallocatechin gallate (OEGCG) and deoxyribonuclease-I (DNase-I). Its functionality was systematically evaluated in vitro and in a diabetic murine wound model using molecular and histological analyses. The O/DNase-I nanocomplex simultaneously eliminates existing NETs via DNase-I-mediated DNA hydrolysis and suppresses further NET formation through OEGCG. This synergistic action robustly cleared NETs, mitigated pro-inflammatory signaling, and critically, promoted a reparative immune microenvironment by driving M2 macrophage polarization, ultimately accelerating diabetic wound closure in vivo. This study not only validates O/DNase-I as a potent therapeutic approach for diabetic wound management but also establishes a novel supramolecular strategy for targeting dysregulated inflammation, with broad potential applications in other NET-associated pathologies.

Keywords

deoxyribonuclease-I / diabetic wound / epigallocatechin gallate / nanocomplex / neutrophil extracellular traps

References

[1] H. Sun, P. Saeedi, S. Karuranga, et al., “IDF Diabetes Atlas: Global, Regional and Country-level Diabetes Prevalence Estimates for 2021 and Projections for 2045,” Diabetes Research and Clinical Practice 183 (2022): 109119.

[2] R. Garibaldi, O. Zbinden, and A. Seidel, “Ulcères diabétiques: Approche Multidisciplinaire En Pratique De Premier Recours [Diabetic Ulcers: A multidisciplinary approach in primary care],” Revue Médicale Suisse 21 (2025): 1665–1669.

[3] F. Zhang, Y. Xia, J. Su, et al., “Neutrophil Diversity and Function in Health and Disease,” Signal Transduction and Targeted Therapy 9 (2024): 343.

[4] C. Liu, S. Yalavarthi, A. Tambralli, et al., “Inhibition of Neutrophil Extracellular Trap Formation Alleviates Vascular Dysfunction in Type 1 Diabetic Mice,” Science Advances 9 (2023): eadj1019.

[5] Y. Xiao, T. Ding, H. Fang, et al., “Innovative Bio-Based Hydrogel Microspheres Micro-Cage for Neutrophil Extracellular Traps Scavenging in Diabetic Wound Healing,” Advanced Science 11 (2024): e2401195.

[6] Z. Zhu, S. Zhou, S. Li, S. Gong, and Q. Zhang, “Neutrophil Extracellular Traps in Wound Healing,” Trends in Pharmacological Sciences 45 (2024): 1033–1045.

[7] Z. Chu, Q. Huang, K. Ma, et al., “Novel Neutrophil Extracellular Trap-related Mechanisms in Diabetic Wounds Inspire a Promising Treatment Strategy With Hypoxia-challenged Small Extracellular Vesicles,” Bioactive Materials 27 (2023): 257–270.

[8] J. Zhou, J. Mei, Q. Liu, et al., “Spatiotemporal On–Off Immunomodulatory Hydrogel Targeting NLRP3 Inflammasome for the Treatment of Biofilm-Infected Diabetic Wounds,” Advanced Functional Materials 33 (2023): 2211811.

[9] S. Zhu, Y. Yu, Y. Ren, et al., “The Emerging Roles of Neutrophil Extracellular Traps in Wound Healing,” Cell Death & Disease 12 (2021): 984.

[10] J. Chen, T. Wang, X. Li, et al., “DNA of Neutrophil Extracellular Traps Promote NF-κB-dependent Autoimmunity via cGAS/TLR9 in Chronic Obstructive Pulmonary Disease,” Signal Transduction and Targeted Therapy 9 (2024): 163.

[11] D. Liu, P. Yang, M. Gao, et al., “NLRP3 activation Induced by Neutrophil Extracellular Traps Sustains Inflammatory Response in the Diabetic Wound,” Clinical Science 133 (2019): 565–582.

[12] H. Shen, C. Zhang, Y. Meng, et al., “Biomimetic Hydrogel Containing Copper Sulfide Nanoparticles and Deferoxamine for Photothermal Therapy of Infected Diabetic Wounds,” Advanced Healthcare Materials 13 (2024): e2303000.

[13] J. Zhang, K. Ji, Y. Ning, et al., “Biological Hyperthermia-Inducing Nanoparticles for Specific Remodeling of the Extracellular Matrix Microenvironment Enhance Pro-Apoptotic Therapy in Fibrosis,” ACS Nano 17 (2023): 10113–10128.

[14] B. Hu, M. Gao, K. O. Boakye-Yiadom, et al., “An Intrinsically Bioactive Hydrogel With on-demand Drug Release Behaviors for Diabetic Wound Healing,” Bioactive Materials 6 (2021): 4592–4606.

[15] N. Li, X. Lu, Y. Yang, et al., “Calcium Peroxide-Based Hydrogel Patch With Sustainable Oxygenation for Diabetic Wound Healing,” Advanced Healthcare Materials 13 (2024): e2303314.

[16] C. J. Wang, G. R. Ko, Y. Y. Lee, et al., “Polymeric DNase-I Nanozymes Targeting Neutrophil Extracellular Traps for the Treatment of Bowel Inflammation,” Nano Convergence 11 (2024): 6.

[17] G. Guo, Z. Liu, J. Yu, et al., “Neutrophil Function Conversion Driven by Immune Switchpoint Regulator Against Diabetes-Related Biofilm Infections,” Advanced Materials 36 (2024): e2310320.

[18] S. L. Wong, M. Demers, K. Martinod, et al., “Diabetes Primes Neutrophils to Undergo NETosis, Which Impairs Wound Healing,” Nature Medicine 21 (2015): 815–819.

[19] J. C. Davis Jr., S. Manzi, C. Yarboro, et al., “Recombinant human Dnase I (rhDNase) in Patients With Lupus Nephritis,” Lupus 8 (1999): 68–76.

[20] K. K. Patel, D. B. Surekha, M. Tripathi, et al., “Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity,” Molecular Pharmaceutics 16 (2019): 3916–3925.

[21] X. Liang, H. Chen, R. Zhang, et al., “Herbal Micelles-loaded ROS-responsive Hydrogel With Immunomodulation and Microenvironment Reconstruction for Diabetic Wound Healing,” Biomaterials 317 (2025): 123076.

[22] J. Weng, Y. Chen, Y. Zeng, et al., “A Novel Hydrogel Loaded With Plant Exosomes and Stem Cell Exosomes as a New Strategy for Treating Diabetic Wounds,” Materials Today Bio 32 (2025): 101810.

[23] I. Mssillou, M. Bakour, M. Slighoua, et al., “Investigation on Wound Healing Effect of Mediterranean Medicinal Plants and some Related Phenolic Compounds: A Review,” Journal of Ethnopharmacology 298 (2022): 115663.

[24] Y. Gong, P. Wang, R. Cao, et al., “Exudate Absorbing and Antimicrobial Hydrogel Integrated With Multifunctional Curcumin-Loaded Magnesium Polyphenol Network for Facilitating Burn Wound Healing,” ACS Nano 17 (2023): 22355–22370.

[25] Z. He, H. Luo, Z. Wang, D. Chen, Q. Feng, and X. Cao, “Injectable and Tissue Adhesive EGCG-laden Hyaluronic Acid Hydrogel Depot for Treating Oxidative Stress and Inflammation,” Carbohydrate Polymers 299 (2023): 120180.

[26] X. Zhao, D. Pei, Y. Yang, et al., “Chronic Diabetic Wound Treatment: Green Tea Derivative Driven Smart Hydrogels With Desired Functions for Chronic Diabetic Wound Treatment,” Advanced Functional Materials 31 (2021): 2170127.

[27] Y. Wu, Y. Wang, C. Zheng, et al., “A Versatile Glycopeptide Hydrogel Promotes Chronic Refractory Wound Healing through Bacterial Elimination, Sustained Oxygenation, Immunoregulation, and Neovascularization,” Advanced Functional Materials 33 (2023): 2305992.

[28] T. Lan, Y. Dong, J. Shi, et al., “Advancing Self-Healing Soy Protein Hydrogel with Dynamic Schiff Base and Metal-Ligand Bonds for Diabetic Chronic Wound Recovery,” Aggregate 5 (2024): e639.

[29] J. Steinmann, J. Buer, T. Pietschmann, and E. Steinmann, “Anti-Infective Properties of Epigallocatechin-3-Gallate (EGCG), a Component of Green Tea,” British Journal of Pharmacology 168 (2013): 1059–1073.

[30] K. Liang, J. E. Chung, S. J. Gao, N. Yongvongsoontorn, and M. Kurisawa, “Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)–Green Tea Catechin Conjugate for Cancer Therapy,” Advanced Materials 30 (2018): e1706963.

[31] N. Yongvongsoontorn, J. E. Chung, S. J. Gao, et al., “Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex Beyond Tumor-Targeted Delivery,” ACS Nano 13 (2019): 7591–7602.

[32] X. Li, Q. Zhou, A. Japir, D. Dutta, N. Lu, and Z. Ge, “Protein-Delivering Nanocomplexes With Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy,” ACS Nano 16 (2022): 14982–14999.

[33] W. Li, M. Yalcin, Q. Lin, M. M. Ardawi, and S. A. Mousa, “Self-assembly of Green Tea Catechin Derivatives in Nanoparticles for Oral Lycopene Delivery,” Journal of Controlled Release 248 (2017): 117–124.

[34] T. Kuzuhara, Y. Sei, K. Yamaguchi, M. Suganuma, and H. Fujiki, “DNA and RNA as New Binding Targets of Green Tea Catechins,” Journal of Biological Chemistry 281 (2006): 17446–17456.

[35] N. A. Singh, A. K. Mandal, and Z. A. Khan, “Potential Neuroprotective Properties of Epigallocatechin-3-gallate (EGCG),” Nutrition Journal 15 (2016): 60.

[36] S. Li, Y. Ma, S. Ye, D. Hu, and F. Xiao, “ERK/p38/ROS Burst Responses to Environmentally Relevant Concentrations of Diphenyl Phosphate-evoked Neutrophil Extracellular Traps Formation: Assessing the Role of Autophagy,” Journal of Hazardous Materials 421 (2022): 126758.

[37] C. Lin, T.-M. Cheng, Y.-C. Liu, et al., “Dual-Targeting EGCG/NO-Supplying Protein Assembled Nanoparticles With Multi-Synergistic Effects Against Atherosclerosis,” Chemical Engineering Journal 493 (2024): 152755.

[38] L. He, R. Liu, H. Yue, et al., “Interaction Between Neutrophil Extracellular Traps and Cardiomyocytes Contributes to Atrial Fibrillation Progression,” Signal Transduction and Targeted Therapy 8 (2023): 279.

[39] J. Behmoaras, K. Mulder, F. Ginhoux, and E. Petretto, “The Spatial and Temporal Activation of Macrophages During Fibrosis,” Nature Reviews Immunology 25 (2025): 816–830.

[40] Z. Li, L. Li, M. Yue, Q. Peng, X. Pu, and Y. Zhou, “Tracing Immunological Interaction in Trimethylamine N-Oxide Hydrogel-Derived Zwitterionic Microenvironment during Promoted Diabetic Wound Regeneration,” Advanced Materials 36 (2024): e2402738.

[41] Y. Zhao, X. Zhu, L. Hu, et al., “Macrophage Membrane-coated Polydopamine Nanomedicine for Treating Acute Lung Injury Through Modulation of Neutrophil Extracellular Traps and M2 Macrophage Polarization,” Materials Today Bio 32 (2025): 101708.

[42] C. Chen, J. Wang, Y. Guo, et al., “Monosodium Urate Crystal-Induced Pyroptotic Cell Death in Neutrophil and Macrophage Facilitates the Pathological Progress of Gout,” Small 20 (2024): e2308749.

[43] M. Babuta, C. Morel, M. de Carvalho Ribeiro, et al., “Neutrophil Extracellular Traps Activate Hepatic Stellate Cells and Monocytes via NLRP3 Sensing in Alcohol-induced Acceleration of MASH Fibrosis,” Gut 73 (2024): 1854–1869.

[44] S. Ye, Y. Ma, S. Li, et al., “Ambient NO2 Hinders Neutrophil Extracellular Trap Formation in Rats: Assessment of the Role of Neutrophil Autophagy,” Journal of Hazardous Materials 457 (2023): 131755.

[45] Z. Mou, Y. Chen, J. Hu, et al., “Icaritin Inhibits the Progression of Urothelial Cancer by Suppressing PADI2-mediated Neutrophil Infiltration and Neutrophil Extracellular Trap Formation,” Acta Pharmaceutica Sinica B 14 (2024): 3916–3930.

[46] G. L. Burn, A. Foti, G. Marsman, D. F. Patel, and A. Zychlinsky, “The Neutrophil,” Immunity 54 (2021): 1377–1391.

[47] I. Liebold, A. A. Jawazneh, C. Casar, et al., “Apoptotic Cell Identity Induces Distinct Functional Responses to IL-4 in Efferocytic Macrophages,” Science 384 (2024): 14.

[48] A. Warnatsch, M. Ioannou, Q. Wang, and V. Papayannopoulos, “Neutrophil Extracellular Traps License Macrophages for Cytokine Production in Atherosclerosis,” Science 349 (2015): 316–320.

[49] H. Huang, J. Hou, M. Li, F. Wei, Y. Liao, and B. Xi, “Microplastics in the Bloodstream Can Induce Cerebral Thrombosis by Causing Cell Obstruction and Lead to Neurobehavioral Abnormalities,” Science Advances 11 (2025): eadr8243.

[50] D. Yılmaz and M. Culha, “Monitoring Lipopolysaccharide-induced Macrophage Polarization by Surface-enhanced Raman Scattering,” Mikrochimica Acta 191 (2024): 548.

[51] O. A. Peña and P. Martin, “Cellular and Molecular Mechanisms of Skin Wound Healing,” Nature Reviews Molecular Cell Biology 25 (2024): 599–616.

[52] Y. Cai, K. Chen, C. Liu, and X. Qu, “Harnessing Strategies for Enhancing Diabetic Wound Healing From the Perspective of Spatial Inflammation Patterns,” Bioactive Materials 28 (2023): 243–254.

[53] A. P. Sawaya, R. C. Stone, S. R. Brooks, et al., “Deregulated Immune Cell Recruitment Orchestrated by FOXM1 Impairs Human Diabetic Wound Healing,” Nature Communications 11 (2020): 4678.

[54] M. Mihlan, S. Wissmann, A. Gavrilov, et al., “Neutrophil Trapping and Nexocytosis, Mast Cell-mediated Processes for Inflammatory Signal Relay,” Cell 187 (2024): 5316–5335.e28.

[55] S. M. Aitcheson, F. D. Frentiu, S. E. Hurn, K. Edwards, and R. Z. Murray, “Skin Wound Healing: Normal Macrophage Function and Macrophage Dysfunction in Diabetic Wounds,” Molecules 26 (2021): 4917.

[56] L. Fan, X. Jia, F. Dong, et al., “Ginseng-derived Nanoparticles Accelerate Diabetic Wound Healing by Modulating Macrophage Polarization and Restoring Endothelial Cell Function,” Materials Today Bio 34 (2025): 102143.

[57] S. A. Eming, P. J. Murray, and E. J. Pearce, “Metabolic Orchestration of the Wound Healing Response,” Cell Metabolism 33 (2021): 1726–1743.

[58] J. Wang, H. Zhang, S. Hu, and L. Ma, “A MMP9-responsive Nanozyme Hydrogel to Promote Diabetic Wound Healing by Reconstructing the Balance of Pro-inflammation and Anti-inflammation,” Journal of Materials Chemistry B 13 (2025): 8083–8093.

[59] J. E. Chung, S. Tan, S. J. Gao, et al., “Self-assembled Micellar Nanocomplexes Comprising Green Tea Catechin Derivatives and Protein Drugs for Cancer Therapy,” Nature Nanotechnology 9 (2014): 907–912.

[60] J. Xue, Z. Zhao, L. Zhang, et al., “Neutrophil-mediated Anticancer Drug Delivery for Suppression of Postoperative Malignant Glioma Recurrence,” Nature Nanotechnology 12 (2017): 692–700.

[61] M. Dong, X. Z. Xiao, Z. G. Su, et al., “Light-Induced ROS Generation and 2-DG-Activated Endoplasmic Reticulum Stress by Antitumor Nanosystems: An Effective Combination Therapy by Regulating the Tumor Microenvironment,” Small 15 (2019): e1900212.

RIGHTS & PERMISSIONS

2026 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.